Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Bast

Showing results (21-30 of 246) with videos related to

Pageof 25
Sort By:
Expert Review of Molecular Diagnostics|May 5, 2017
The role of biomarkers in the management of epithelial ovarian cancerWei-Lei Yang, Zhen Lu, Robert C Bast
Cancer|October 31, 2014
How will we recruit, train, and retain physicians and scientists to conduct translational cancer research?Curtis R Pickering, Robert C Bast, Khandan Keyomarsi
Oncology (Williston Park, N.Y.)|August 6, 2013
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasArchana R Simmons, Keith Baggerly, Robert C Bast
Nature Reviews. Cancer|May 23, 2009
The biology of ovarian cancer: new opportunities for translationRobert C Bast, Bryan Hennessy, Gordon B Mills
Gynecologic Oncology|November 3, 2009
Current state of biomarker development for clinical application in epithelial ovarian cancerRichard G Moore, Shannon MacLaughlan, Robert C Bast
Cell Cycle (Georgetown, Tex.)|December 22, 2004
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathwaysXiao-Feng Le, Franz Pruefer, Robert C Bast
Gynecologic Oncology|October 10, 2006
Biomarkers and clinical trial designJohn Farley, Robert C Bast, Michael J Birrer
Hematology/Oncology Clinics of North America|November 5, 2018
Early Detection of Ovarian CancerKevin M Elias, Jing Guo, Robert C Bast
Clinical Chemistry|December 4, 2012
Conquering cancer in our lifetime: new diagnostic and therapeutic trendsEleftherios P Diamandis, Robert C Bast, Carlos Lopez-Otín
Current Oncology Reports|July 27, 2019
Novel Approaches to Ovarian Cancer ScreeningDenise R Nebgen, Karen H Lu, Robert C Bast
Pageof 25

Showing results (21-30 of 246) with videos related to

Sort By:
Pageof 25
Expert Review of Molecular Diagnostics|May 5, 2017
The role of biomarkers in the management of epithelial ovarian cancerWei-Lei Yang, Zhen Lu, Robert C Bast
Cancer|October 31, 2014
How will we recruit, train, and retain physicians and scientists to conduct translational cancer research?Curtis R Pickering, Robert C Bast, Khandan Keyomarsi
Oncology (Williston Park, N.Y.)|August 6, 2013
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasArchana R Simmons, Keith Baggerly, Robert C Bast
Nature Reviews. Cancer|May 23, 2009
The biology of ovarian cancer: new opportunities for translationRobert C Bast, Bryan Hennessy, Gordon B Mills
Gynecologic Oncology|November 3, 2009
Current state of biomarker development for clinical application in epithelial ovarian cancerRichard G Moore, Shannon MacLaughlan, Robert C Bast
Cell Cycle (Georgetown, Tex.)|December 22, 2004
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathwaysXiao-Feng Le, Franz Pruefer, Robert C Bast
Gynecologic Oncology|October 10, 2006
Biomarkers and clinical trial designJohn Farley, Robert C Bast, Michael J Birrer
Hematology/Oncology Clinics of North America|November 5, 2018
Early Detection of Ovarian CancerKevin M Elias, Jing Guo, Robert C Bast
Clinical Chemistry|December 4, 2012
Conquering cancer in our lifetime: new diagnostic and therapeutic trendsEleftherios P Diamandis, Robert C Bast, Carlos Lopez-Otín
Current Oncology Reports|July 27, 2019
Novel Approaches to Ovarian Cancer ScreeningDenise R Nebgen, Karen H Lu, Robert C Bast
Pageof 25